{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-062536","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2026-05-15T20:10:34+00:00","discovered_at":"2026-05-15T20:17:00.231542+00:00","generated_at":"2026-05-15T20:17:21.227748+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte","bullets":["All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.","Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.","Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.","Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-062536","json":"https://secwatch.observer/filing/0001104659-26-062536.json","markdown":"https://secwatch.observer/filing/0001104659-26-062536.md","text":"https://secwatch.observer/filing/0001104659-26-062536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/tm2614189d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T20:17:21.227748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0dcb5932bca56b87c690923e0df4a8cdae162375","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders at the 2026-05-14 meeting.","evidence_excerpt":"PROPOSAL 1 : Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"},{"claim_id":"7783f24ad50bf6753f8ea0deabc65e5d820db2ab","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers at the 2026-05-14 meeting.","evidence_excerpt":"PROPOSAL 2: Approval of, on an advisory basis, the compensation of the Company’s named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"},{"claim_id":"dae54056dde188d734175deeee861181a1857ca1","claim":"COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.","evidence_excerpt":"PROPOSAL 3 : Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-05-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}